Itching in drug-induced liver injury study
Part of Digestive system, Skin clinical trials.
This study looks at itching caused by drug-induced liver injury. Researchers want to understand who gets itchy and how bad it is, which could help improve care for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have liver injury caused by a drug or other substance
- Your liver test results must meet certain high levels (like ALT or alkaline phosphatase) at the time of screening
- You do not have other skin conditions like eczema or hives that cause itching
- You do not have hepatitis B, C, or E
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how often drug-induced liver injury occurs and how it affects patients over time. If you join, researchers will track your health to learn more about recovery and long-term outcomes.
This trial sets up a patient library for people who have itching with no clear underlying skin or medical cause. It aims to collect patient input and experiences to improve understanding and support for this condition.
This Phase 3 study tests whether dupilumab injections can reduce severe itching that has no clear cause. It also checks how safe the medicine is over the study period.
This study puts people with a past drug- or herbal-related liver injury into a research registry. The goal is to better understand why the injury happens so doctors can prevent and recognize it sooner.
This study continues to test an experimental medicine (linerixibat) for itching caused by primary biliary cholangitis (PBC). It's for people who have already been in a prior study of this medicine and may help keep itching under control.
This study follows people who developed liver injury from a medicine (not from other causes). It aims to better describe different types and severities of drug-related liver injury and may help improve how clinicians recognize and manage it.
Hear when a new Drug Induced Liver Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.